Low dose rapamycin in a study was shown to increase interferon antiviral response. Participants reported lower rates of infections for 1 year. Improved T cell response. This drug is being trialed for . Amy Proal PhD 🧵
“Low dose rapamycin in a study was shown to increase interferon antiviral response. Participants reported lower rates of infections for 1 year. Improved T cell response. This drug is being trialed for #LongCovid. Amy Proal PhD @microbeminded2 🧵”